BerandaCYBN • NYSEAMERICAN
add
Cybin Inc
$7,45
Setelah Jam Perdagangan Normal:(0,28%)+0,021
$7,47
Tutup: 16 Apr, 19.40.28 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$7,70
Rentang hari
$7,20 - $7,89
Rentang tahun
$4,81 - $14,44
Volume Rata-Rata
240,75Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 31,33Â jt | 15,94% |
Laba bersih | -10,54Â jt | 65,24% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,53 | 84,50% |
EBITDA | -31,28Â jt | -16,41% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 136,29Â jt | 249,47% |
Total aset | 253,55Â jt | 95,45% |
Total liabilitas | 13,31Â jt | 56,49% |
Total ekuitas | 240,24 jt | — |
Saham yang beredar | 21,04 jt | — |
Harga terhadap nilai buku | 0,64 | — |
Tingkat pengembalian aset | -30,36% | — |
Tingkat pengembalian modal | -31,62% | — |
Arus Kas
Perubahan kas bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -10,54Â jt | 65,24% |
Kas dari operasi | -27,12Â jt | -4,15% |
Kas dari investasi | -303,00Â rb | -104,06% |
Kas dari pembiayaan | -179,00Â rb | -100,45% |
Perubahan kas bersih | -18,03Â jt | -186,34% |
Arus kas bebas | -17,34Â jt | -88,49% |
Tentang
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
50
